Carbon Nanotube-Mediated Photothermal Disruption of Endosomes/Lysosomes Reverses Doxorubicin Resistance in MCF-7/ADR Cells

被引:34
作者
Pai, Chin-Ling [1 ]
Chen, Yu-Chun [2 ]
Hsu, Chia-Yen [2 ]
Su, Hong-Lin [1 ,3 ]
Lai, Ping-Shan [1 ,2 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 402, Taiwan
[2] Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan
[3] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan
关键词
Carbon Nanotubes; Doxorubicin; Drug Resistance; Breast Cancer; Photothermal Treatments; BREAST-CANCER CELLS; DRUG-DELIVERY; IN-VIVO; PHOTOCHEMICAL INTERNALIZATION; MULTIDRUG-RESISTANCE; P-GLYCOPROTEINS; TRANSPORTERS; THERAPY; FUNCTIONALIZATION; ANTIBODY;
D O I
10.1166/jbn.2016.2133
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Cancer is the leading cause of human death worldwide. Although many scientists work to fight this disease, multiple drug resistance is a predominant obstacle for effective cancer therapy. In drug-resistant MCF-7/ADR cells, the acidic organelles with lower pH value than normal one can cause the protonation of anthracycline drugs, inducing drug accumulation in these organelles. In this study, single-walled carbon nanotubes with polyethylene glycol phospholipids surface modification (PEGylated SWNTs) were utilized as near infrared-activated drug carriers for doxorubicin (DOX) delivery against MCF-7/ADR cells. Our results showed that a concentration-dependent temperature increase was observed in a solution of PEGylated SWNTs with 808 nm laser irradiation, whereas a water solution showed no significant changes in temperature under a thermal camera using the same irradiation dose. Interestingly, PEGylated DOX-SWNTs enhanced the nuclear accumulation of DOX with 808 nm irradiation whereas free DOX or PEGylated DOX-SWNTs revealed discrete red spots in MCF-7/ADR cells by confocal microscopic observation. Cell viability of PEGylated DOX-SWNTs-treated cells was also significantly decreased after 808 nm laser irradiation. Thus, photothermally activated PEGylated SWNTs can be a potential nanocarrier to deliver DOX into cancer cells and successfully overcome drug-resistant behavior in MCF-7/ADR breast cancer cells.
引用
收藏
页码:619 / 629
页数:11
相关论文
共 50 条
  • [41] Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin
    Chekhun, Vasyl F.
    Lukyanova, Natalia Yu
    Burlaka, Anatoliy P.
    Bezdenezhnykh, Natalia A.
    Shpyleva, Svitlana I.
    Tryndyak, Volodymyr P.
    Beland, Frederick A.
    Pogribny, Igor P.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (05) : 1481 - 1486
  • [42] Synergistic Therapy of Doxorubicin with Cationic Anticancer Peptide L-K6 Reverses Multidrug Resistance in MCF-7/ADR Cancer Cells In Vitro via P-glycoprotein Inhibition
    Che Wang
    Lili Huang
    Ruojin Li
    Ying Wang
    Xiaoxue Wu
    Dejing Shang
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 2291 - 2301
  • [43] Synergistic Therapy of Doxorubicin with Cationic Anticancer Peptide L-K6 Reverses Multidrug Resistance in MCF-7/ADR Cancer Cells In Vitro via P-glycoprotein Inhibition
    Wang, Che
    Huang, Lili
    Li, Ruojin
    Wang, Ying
    Wu, Xiaoxue
    Shang, Dejing
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2291 - 2301
  • [44] Pien Tze Huang (片仔癀) Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells
    Xi Chen
    Fei Qi
    A-ling Shen
    Jian-feng Chu
    Thomas Joseph Sferra
    You-qin Chen
    Jun Peng
    Chinese Journal of Integrative Medicine, 2019, 25 : 598 - 603
  • [45] Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance
    范国昌
    吴祖泽
    Chinese Journal of Cancer Research, 2000, (03) : 19 - 25
  • [46] MiR-221 Expression Level Correlates with Insulin-Induced Doxorubicin Resistance in MCF-7 Breast Cancer Cells
    Kheradmand, Parisa
    Boroojeni, Sadeq Vallian
    Esmaeili-Mahani, Saeed
    CELL JOURNAL, 2021, 23 (03) : 329 - 334
  • [47] Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance
    Fan, GC
    Wu, CT
    CANCER LETTERS, 2000, 158 (02) : 203 - 210
  • [48] Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex
    Han, Min
    Lv, Qing
    Tang, Xin-Jiang
    Hu, Yu-Lan
    Xu, Dong-Hang
    Li, Fan-Zhu
    Liang, Wen-Quan
    Gao, Jian-Qing
    JOURNAL OF CONTROLLED RELEASE, 2012, 163 (02) : 136 - 144
  • [49] Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins
    Hu, Yunhui
    Cheng, Xin
    Li, Shuangjing
    Zhou, Yuan
    Wang, Jianxiang
    Cheng, Tao
    Yang, Ming
    Xiong, Dongsheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 789 - 798
  • [50] Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells
    Liu, Ming
    Zhang, Weiyi
    Tang, Wei
    Wang, Yanjuan
    Zhao, Xingzeng
    Wang, Xiangyun
    Qi, Xin
    Li, Jing
    TUMOR BIOLOGY, 2016, 37 (02) : 1919 - 1931